Pure Global AI
NCT06239961Not yet recruiting

Behavioral Activation, Nutrition, and Activity Intervention

Multi-Component Behavioral Activation, Nutrition, and Activity Intervention for Persons Aging With HIV
University of Maryland, BaltimoreClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
HIV
Drug/Device/Intervention
Social Connection
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Maryland, Baltimore
Location
Baltimore, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 06, 2024
End date
May 30, 2026
Enrollment
10 participants
Primary outcome

Depression,Loneliness,Social Isolation,Physical Activity (actigraphy) steps,Physical Activity (actigraphy) sedentary time,Total Sleep Time (TST) with Actigraphy,Sleep Efficiency (SE) with Actigraphy,Sleep Onset Latency (SOL) with Actigraphy,Nutritional Intake

Summary

This study will explore if a behavioral intervention program to assist people aged 50 and
 older with HIV is practical. The program includes a coach who talks with participants,
 encouraging them to be more active, reduce loneliness, and eat healthier.

ICD-10 classifications
Human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other conditionsHIV disease resulting in other viral infectionsUnspecified human immunodeficiency virus [HIV] diseaseHuman immunodeficiency virus [HIV] disease resulting in other specified diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06239961
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06239961 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Maryland, Baltimore and is currently Not yet recruiting. The study focuses on HIV. Target enrollment is 10 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.